These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9405242

  • 1. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.
    Hirai H, Satoh E, Osawa M, Inaba T, Shimazaki C, Kinoshita S, Nakagawa M, Mazda O, Imanishi J.
    Biochem Biophys Res Commun; 1997 Dec 08; 241(1):112-8. PubMed ID: 9405242
    [Abstract] [Full Text] [Related]

  • 2. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
    Tanaka S, Iwai M, Harada Y, Morikawa T, Muramatsu A, Mori T, Okanoue T, Kashima K, Maruyama-Tabata H, Hirai H, Satoh E, Imanishi J, Mazda O.
    Cancer Gene Ther; 2000 Sep 08; 7(9):1241-50. PubMed ID: 11023196
    [Abstract] [Full Text] [Related]

  • 3. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer.
    Harada Y, Iwai M, Tanaka S, Okanoue T, Kashima K, Maruyama-Tabata H, Hirai H, Satoh E, Imanishi J, Mazda O.
    Cancer Gene Ther; 2000 Jan 08; 7(1):27-36. PubMed ID: 10678353
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
    Izumo T, Ohtsuru A, Tokunaga Y, Namba H, Kaneda Y, Nagata I, Yamashita S.
    Int J Oncol; 2007 Aug 08; 31(2):379-87. PubMed ID: 17611695
    [Abstract] [Full Text] [Related]

  • 5. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer.
    Maruyama-Tabata H, Harada Y, Matsumura T, Satoh E, Cui F, Iwai M, Kita M, Hibi S, Imanishi J, Sawada T, Mazda O.
    Gene Ther; 2000 Jan 08; 7(1):53-60. PubMed ID: 10680016
    [Abstract] [Full Text] [Related]

  • 6. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, Krisky DM, Oligino T, Glorioso JC, Curiel TJ, Curiel DT.
    Biochem Biophys Res Commun; 1998 Nov 27; 252(3):686-90. PubMed ID: 9837767
    [Abstract] [Full Text] [Related]

  • 7. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
    Hasegawa H, Shimada M, Yonemitsu Y, Utsunomiya T, Gion T, Kaneda Y, Sugimachi K.
    Cancer Gene Ther; 2001 Apr 27; 8(4):252-8. PubMed ID: 11393277
    [Abstract] [Full Text] [Related]

  • 8. Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector.
    Iwai M, Harada Y, Tanaka S, Muramatsu A, Mori T, Kashima K, Imanishi J, Mazda O.
    Biochem Biophys Res Commun; 2002 Feb 15; 291(1):48-54. PubMed ID: 11829460
    [Abstract] [Full Text] [Related]

  • 9. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD, Boenicke L, Schniewind B, Henne-Bruns D, Kalthoff H.
    Cancer Gene Ther; 2000 Jun 15; 7(6):927-38. PubMed ID: 10880025
    [Abstract] [Full Text] [Related]

  • 10. Adenoviral vectors efficiently target cell lines derived from selected lymphocytic malignancies, including anaplastic large cell lymphoma and Hodgkin's disease.
    Meeker TC, Lay LT, Wroblewski JM, Turturro F, Li Z, Seth P.
    Clin Cancer Res; 1997 Mar 15; 3(3):357-64. PubMed ID: 9815692
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar 15; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

  • 12. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
    Lifang Y, Min T, Midan A, Ya C.
    J Exp Clin Cancer Res; 2008 Sep 23; 27(1):42. PubMed ID: 18811956
    [Abstract] [Full Text] [Related]

  • 13. Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.
    Hasegawa Y, Nishiyama Y, Imaizumi K, Ono N, Kinoshita T, Hatano S, Saito H, Shimokata K.
    Cancer Gene Ther; 2000 Apr 23; 7(4):557-62. PubMed ID: 10811473
    [Abstract] [Full Text] [Related]

  • 14. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
    Saeki Y, Wataya-Kaneda M, Tanaka K, Kaneda Y.
    Gene Ther; 1998 Aug 23; 5(8):1031-7. PubMed ID: 10326025
    [Abstract] [Full Text] [Related]

  • 15. Suicide gene therapy of hepatocellular carcinoma and delivery procedure and route of therapeutic gene in vivo.
    Sun XY, Wu ZD, Hu JB.
    Hepatobiliary Pancreat Dis Int; 2002 Aug 23; 1(3):373-7. PubMed ID: 14607709
    [Abstract] [Full Text] [Related]

  • 16. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
    Wildner O, Hoffmann D, Jogler C, Uberla K.
    Cancer Gene Ther; 2003 Oct 23; 10(10):791-802. PubMed ID: 14502232
    [Abstract] [Full Text] [Related]

  • 17. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
    Mũcke S, Polack A, Pawlita M, Zehnpfennig D, Massoudi N, Bohlen H, Doerfler W, Bornkamm G, Diehl V, Wolf J.
    Gene Ther; 1997 Feb 23; 4(2):82-92. PubMed ID: 9081710
    [Abstract] [Full Text] [Related]

  • 18. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
    Wendelburg BJ, Vos JM.
    Gene Ther; 1998 Oct 23; 5(10):1389-99. PubMed ID: 9930345
    [Abstract] [Full Text] [Related]

  • 19. Gene transfer in hepatocarcinoma cell lines: in vitro optimization of a virus-free system.
    Ghoumari AM, Rixe O, Yarovoi SV, Zerrouqi A, Mouawad R, Poynard T, Opolon P, Khayat D, Soubrane C.
    Gene Ther; 1996 Jun 23; 3(6):483-90. PubMed ID: 8789797
    [Abstract] [Full Text] [Related]

  • 20. Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome.
    Satoh E, Osawa M, Tomiyasu K, Hirai H, Shimazaki C, Oda Y, Nakagawa M, Kondo M, Kinoshita S, Mazda O, Imanishi J.
    Biochem Biophys Res Commun; 1997 Sep 29; 238(3):795-9. PubMed ID: 9325170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.